What Sponsors Should Really Be Asking in CRO RFPs

Most CRO RFPs are built by biotech and emerging biopharma around capabilities and pricing grids. They ask what a CRO can do and what it costs. They rarely ask what happens when momentum falters, timelines stall, or the study runs aground on a risk no one charted.

The questions that actually determine success are the ones CROs would prefer not to answer directly. These are the questions that change the conversation:

1. Who, specifically, stays on this study through database lock?

Look for named commitments and turnover assumptions.

What it reveals: whether your study is staffed with the people who sold it or backfilled with whoever's available.

2. How does an issue reach me, and how fast?

Ask for the escalation path by name and timeframe—not a flowchart.

What it reveals: whether problems surface early or are managed into silence until they are crises.

3. What does your governance model expect of us as sponsor?

A CRO that cannot define your oversight role is one that will either over-manage you or leave a vacuum.

What it reveals: clarity (or absence) of the operating partnership.

4. How are your performance metrics defined, reported, and acted upon?

Don't accept "we track KPIs." Ask which ones trigger intervention and how.

What it reveals: whether metrics drive decisions or just decorate dashboards.

5. What real-time data and system access do sponsors get?

Transparency is an operating choice, not a deliverable.

What it reveals: whether you'll inspect the work or just receive reports about it.

6. How have you operationalized ICH E6(R3)?

Ask where the risk-proportionate, critical-to-quality approach actually changed a study design or monitoring plan.

What it reveals: whether E6(R3) is embedded in how they think, or bolted on as a compliance line item.

7. When a study goes off track, what changes?

Ask for a recent example and what was actually adjusted.

What it reveals: adaptive muscle versus crisis firefighting.

8. How do you stay inspection-ready—and prove it between audits?

Quality culture shows up between inspections, not during them.

What it reveals: whether readiness is embedded or performed.

A typical RFP evaluates capabilities. A strategic RFP evaluates the operating model behind them.

The quality of your RFP determines the quality of your partnership—and, ultimately, your timeline.

If you are thinking about your outsourcing approach, ABRA Clinical Consulting helps biotech and emerging biopharma sponsors build RFPs that pressure-test operating models, not just CRO capabilities and pricing.  Let's talk!

An RFP that asks these questions takes a draft or two to get right. ABRA writes them with sponsors, under RFP development and process management.